Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group Statistics

Total Valuation

MREO has a market cap or net worth of $297.58 million. The enterprise value is $249.28 million.

Market Cap	297.58M
Enterprise Value	249.28M

Important Dates

The last earnings date was Monday, November 10, 2025, after market close.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

MREO has 159.13 million shares outstanding. The number of shares has increased by 9.71% in one year.

Current Share Class	n/a
Shares Outstanding	159.13M
Shares Change (YoY)	+9.71%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	4.99%
Owned by Institutions (%)	42.68%
Float	99.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	595.15
Forward PS	n/a
PB Ratio	6.38
P/TBV Ratio	6.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	498.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.71, with a Debt / Equity ratio of 0.01.

Current Ratio	8.71
Quick Ratio	8.35
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-74.69

Financial Efficiency

Return on equity (ROE) is -69.79% and return on invested capital (ROIC) is -44.90%.

Return on Equity (ROE)	-69.79%
Return on Assets (ROA)	-39.81%
Return on Invested Capital (ROIC)	-44.90%
Return on Capital Employed (ROCE)	-95.28%
Revenue Per Employee	$13,889
Profits Per Employee	-$1.15M
Employee Count	36
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.47% in the last 52 weeks. The beta is 0.38, so MREO's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-47.47%
50-Day Moving Average	1.91
200-Day Moving Average	2.15
Relative Strength Index (RSI)	52.13
Average Volume (20 Days)	1,332,316

Short Selling Information

Short Interest	9.25M
Short Previous Month	10.12M
Short % of Shares Out	8.17%
Short % of Float	n/a
Short Ratio (days to cover)	6.07

Income Statement

In the last 12 months, MREO had revenue of $500,000 and -$41.57 million in losses. Loss per share was -$0.26.

Revenue	500,000
Gross Profit	367,000
Operating Income	-45.34M
Pretax Income	-41.57M
Net Income	-41.57M
EBITDA	-45.03M
EBIT	-45.34M
Loss Per Share	-$0.26

Balance Sheet

The company has $48.70 million in cash and $397,000 in debt, giving a net cash position of $48.30 million or $0.30 per share.

Cash & Cash Equivalents	48.70M
Total Debt	397,000
Net Cash	48.30M
Net Cash Per Share	$0.30
Equity (Book Value)	46.60M
Book Value Per Share	0.29
Working Capital	46.39M

Cash Flow

In the last 12 months, operating cash flow was -$32.71 million and capital expenditures -$20,000, giving a free cash flow of -$32.73 million.

Operating Cash Flow	-32.71M
Capital Expenditures	-20,000
Free Cash Flow	-32.73M
FCF Per Share	-$0.21

Margins

Gross Margin	73.40%
Operating Margin	-9,067.80%
Pretax Margin	-8,314.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MREO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.71%
Shareholder Yield	-9.71%
Earnings Yield	-13.97%
FCF Yield	-11.00%

Analyst Forecast

The average price target for MREO is $7.40, which is 295.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.40
Price Target Difference	295.72%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MREO has an Altman Z-Score of 22.26 and a Piotroski F-Score of 2.

Altman Z-Score	22.26
Piotroski F-Score	2